Pfizer Announces Start of Phase 3 Clinical Trial in Adults for its Investigational Vaccine Against Respiratory Syncytial Virus (RSV)
September 3, 2021
Pfizer Inc. (NYSE:PFE) today announced the initiation of RENOIR (RSV vaccine Efficacy study iNOlder adults Immunized against RSV disease), a Phase 3 clinical trial evaluating the efficacy, immunogenicity, and safety of a single dose of its respiratory syncytial ...
chat_bubble0 Comment
visibility58 Views
NuvoAir Respiratory Platform Shows Promise for Long-Term Remote Monitoring of Asthma
August 27, 2021
Three new studies show how home monitoring technology – developed by leading digital health company NuvoAir – can be successfully used by both adults and children living with asthma. These findings pave the way for improved treatment ...
chat_bubble0 Comment
visibility312 Views
Rising Demand for Needle-free Vaccines to Drive Innovation in the Respiratory Virus Vaccines Market
July 14, 2021
A vaccination refers to a biological product that is utilized to provide acquired immunity against a variety of infections that can be dangerous. It is given to protect the susceptible people against a certain disease. A ...
chat_bubble0 Comment
visibility76 Views
Popular Posts
